发明申请
- 专利标题: ORAL FORMULATION FOR DEXLANSOPRAZOLE
- 专利标题(中): 口服奥美拉唑的口服制剂
-
申请号: US13510924申请日: 2010-11-18
-
公开(公告)号: US20130273171A1公开(公告)日: 2013-10-17
- 发明人: Zhiqun Shen , Yu Zhang , Enjun Fu , MIn Michael He , Fang-yu Liu
- 申请人: Zhiqun Shen , Yu Zhang , Enjun Fu , MIn Michael He , Fang-yu Liu
- 申请人地址: US CA Fremont
- 专利权人: HANDA PHARMACEUTICALS, LLC
- 当前专利权人: HANDA PHARMACEUTICALS, LLC
- 当前专利权人地址: US CA Fremont
- 国际申请: PCT/US10/57280 WO 20101118
- 主分类号: A61K31/4439
- IPC分类号: A61K31/4439
摘要:
A stable formulation of dexlansoprazole for treating a digestive disorder, and methods of manufacturing the same.